322 related articles for article (PubMed ID: 28743305)
1. Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.
Bahmer T; Kirsten AM; Waschki B; Rabe KF; Magnussen H; Kirsten D; Gramm M; Hummler S; Brunnemer E; Kreuter M; Watz H
BMC Pulm Med; 2017 Jul; 17(1):104. PubMed ID: 28743305
[TBL] [Abstract][Full Text] [Related]
2. Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis.
Bahmer T; Kirsten AM; Waschki B; Rabe KF; Magnussen H; Kirsten D; Gramm M; Hummler S; Brunnemer E; Kreuter M; Watz H
Respiration; 2016; 91(6):497-502. PubMed ID: 27240427
[TBL] [Abstract][Full Text] [Related]
3. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
Serajeddini H; Rogliani P; Mura M
Lung; 2018 Dec; 196(6):707-713. PubMed ID: 30151723
[TBL] [Abstract][Full Text] [Related]
4. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
[TBL] [Abstract][Full Text] [Related]
5. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.
Zappala CJ; Latsi PI; Nicholson AG; Colby TV; Cramer D; Renzoni EA; Hansell DM; du Bois RM; Wells AU
Eur Respir J; 2010 Apr; 35(4):830-6. PubMed ID: 19840957
[TBL] [Abstract][Full Text] [Related]
6. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
[TBL] [Abstract][Full Text] [Related]
7. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U
Respiration; 2017; 93(6):415-423. PubMed ID: 28399537
[TBL] [Abstract][Full Text] [Related]
8. Changes in physical activity in people with idiopathic pulmonary fibrosis before and after virtual pulmonary rehabilitation: a feasibility study.
O'Shea O; Murphy G; Fox L; O'Reilly KMA
BMC Pulm Med; 2024 May; 24(1):215. PubMed ID: 38698361
[TBL] [Abstract][Full Text] [Related]
9. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
10. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
[TBL] [Abstract][Full Text] [Related]
11. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis.
Caminati A; Bianchi A; Cassandro R; Mirenda MR; Harari S
Respir Med; 2009 Jan; 103(1):117-23. PubMed ID: 18786822
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody status is not associated with change in lung function or survival in patients with idiopathic pulmonary fibrosis.
Goobie GC; Ford-Sahibzada CA; Fritzler MJ; Johannson KA; Fell CD
Respir Med; 2019 Jul; 153():85-90. PubMed ID: 31176275
[TBL] [Abstract][Full Text] [Related]
13. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis.
Chambers DC; Enever D; Ilic N; Sparks L; Whitelaw K; Ayres J; Yerkovich ST; Khalil D; Atkinson KM; Hopkins PM
Respirology; 2014 Oct; 19(7):1013-8. PubMed ID: 25039426
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
Vainshelboim B; Oliveira J; Fox BD; Kramer MR
Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
[TBL] [Abstract][Full Text] [Related]
15. [
Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
[TBL] [Abstract][Full Text] [Related]
16. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.
Khadawardi H; Mura M
Respirology; 2017 Apr; 22(3):501-507. PubMed ID: 27862639
[TBL] [Abstract][Full Text] [Related]
17. Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosis.
Nishiyama O; Yamazaki R; Sano H; Iwanaga T; Higashimoto Y; Kume H; Tohda Y
Respirology; 2017 Apr; 22(3):480-485. PubMed ID: 27868303
[TBL] [Abstract][Full Text] [Related]
18. Short- and Long-Term Reliability of the 6-Minute Walk Test in People With Idiopathic Pulmonary Fibrosis.
Holland AE; Hill CJ; Dowman L; Glaspole I; Goh N; Lee AL; McDonald CF
Respir Care; 2018 Aug; 63(8):994-1001. PubMed ID: 29945909
[TBL] [Abstract][Full Text] [Related]
19. Rising stars of DPLD survival: FVC and exercise desaturation (a single-center study).
Öztürk A; Kayacan O
Turk J Med Sci; 2018 Aug; 48(4):826-832. PubMed ID: 30119159
[TBL] [Abstract][Full Text] [Related]
20. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
